Searchable abstracts of presentations at key conferences in endocrinology

ea0020p185 | Endocrine tumours and neoplasia | ECE2009

Estradiol influences somatostatin receptor expression and potentiates the effects of SOM230 on prostate cells

Rossi Valentina , Bellastella Giuseppe , Visconti Daniela , Abbondanza Ciro , Maione Luigi , Bellastella Antonio , Agostino Sinisi Antonio

Somatostatin (SS) receptors (SSR) expression may be modulated by estrogens in breast cancer cells. Aim of this study was to evaluate the effects of estradiol (E2) on SSR levels in prostate epithelial cells (PEC).Methods: We investigated the effects of E2 and SS-analogue SOM230 combined treatment on two PEC lines: EPN that expresses both ERalfa and beta and CPEC, showing no ERalfa and very low ERbeta expression. Cells starved in red ...

ea0016s30.1 | Clinical highlights | ECE2008

Reversible Kallmann syndrome associated with a novel homozygous mutation in the prokineticin receptor-2 gene

Asci Roberta , Bellastella Giuseppe , Maione Luigi , Quinto Maria Chiara , De Bellis Annamaria , Jolascon Achille , Bellastella Antonio , Agostino Sinisi Antonio

Reversible Kallmann syndrome (KS) is a rare variant of hypogonadotropic hypogonadism (HH) reported in men, in which gonadotropin, testosterone (T) and fertility recover spontaneously following treatment with gonadotropins or T. In a few cases mutations of FGFR1 and KAL1 genes have been found. In this report we describe a subject with a KS carrying a new homozygous mutation of PROK-R2 gene and displaying an apparent reversal of his reproductive condition. The proband, born from...